Literature DB >> 26186123

Host-virus interactions in hepatitis B virus infection.

Luca G Guidotti1, Masanori Isogawa2, Francis V Chisari3.   

Abstract

Hepatitis B virus (HBV) is a noncytopathic, hepatotropic, double-stranded DNA virus that causes acute and chronic hepatitis. Although HBV does not induce a measurable innate immune response in the infected liver, the outcome of infection is determined by the kinetics, breadth, vigor, trafficking, and effector functions of HBV-specific adaptive T cell responses, and the development of neutralizing antibodies. Dysregulation of one or more of these events leads to persistent HBV infection and a variably severe chronic necroinflammatory liver disease that fosters the development of hepatocellular carcinoma. Deeper understanding of the mechanisms responsible for immunological tolerance to HBV is needed in order to devise immunotherapeutic strategies to cure chronic HBV infection and prevent its life-threatening sequelae.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26186123      PMCID: PMC4593767          DOI: 10.1016/j.coi.2015.06.016

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  57 in total

1.  Platelets mediate cytotoxic T lymphocyte-induced liver damage.

Authors:  Matteo Iannacone; Giovanni Sitia; Masanori Isogawa; Patrizia Marchese; Maria G Castro; Pedro R Lowenstein; Francis V Chisari; Zaverio M Ruggeri; Luca G Guidotti
Journal:  Nat Med       Date:  2005-10-30       Impact factor: 53.440

Review 2.  HBV and the immune response.

Authors:  Carlo Ferrari
Journal:  Liver Int       Date:  2015-01       Impact factor: 5.828

3.  Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

Authors:  Masanori Isogawa; Michael D Robek; Yoshihiro Furuichi; Francis V Chisari
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Immune tolerance split between hepatitis B virus precore and core proteins.

Authors:  Margaret Chen; Matti Sällberg; Janice Hughes; Joyce Jones; Luca G Guidotti; Francis V Chisari; Jean-Noel Billaud; David R Milich
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

Authors:  Jean Publicover; Anuj Gaggar; Stephen Nishimura; Christine M Van Horn; Amanda Goodsell; Marcus O Muench; R Lee Reinhardt; Nico van Rooijen; Adil E Wakil; Marion Peters; Jason G Cyster; David J Erle; Philip Rosenthal; Stewart Cooper; Jody L Baron
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

6.  Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.

Authors:  Sebastian Zeissig; Kazumoto Murata; Lindsay Sweet; Jean Publicover; Zongyi Hu; Arthur Kaser; Esther Bosse; Jahangir Iqbal; M Mahmood Hussain; Katharina Balschun; Christoph Röcken; Alexander Arlt; Rainer Günther; Jochen Hampe; Stefan Schreiber; Jody L Baron; D Branch Moody; T Jake Liang; Richard S Blumberg
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

7.  IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.

Authors:  Abhishek Das; Gidon Ellis; Celeste Pallant; A Ross Lopes; Pooja Khanna; Dimitra Peppa; Antony Chen; Paul Blair; Geoffrey Dusheiko; Upkar Gill; Patrick T Kennedy; Maurizia Brunetto; Pietro Lampertico; Claudia Mauri; Mala K Maini
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

8.  Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.

Authors:  Gaia Nebbia; Dimitra Peppa; Anna Schurich; Pooja Khanna; Harsimran D Singh; Yang Cheng; William Rosenberg; Geoffrey Dusheiko; Richard Gilson; Joanne ChinAleong; Patrick Kennedy; Mala K Maini
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells.

Authors:  Anna Schurich; Laura J Pallett; Marcin Lubowiecki; Harsimran D Singh; Upkar S Gill; Patrick T Kennedy; Eleni Nastouli; Sudeep Tanwar; William Rosenberg; Mala K Maini
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

10.  Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.

Authors:  Dimitra Peppa; Upkar S Gill; Gary Reynolds; Nicholas J W Easom; Laura J Pallett; Anna Schurich; Lorenzo Micco; Gaia Nebbia; Harsimran D Singh; David H Adams; Patrick T F Kennedy; Mala K Maini
Journal:  J Exp Med       Date:  2012-12-17       Impact factor: 14.307

View more
  54 in total

1.  The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans.

Authors:  Danilo Di Bona; Janardan P Pandey; Anna Aiello; Massimo Bilancia; Giuseppina Candore; Calogero Caruso; Claudia Colomba; Giovanni Duro; Mattia Emanuela Ligotti; Luigi Macchia; Sergio Rizzo; Giulia Accardi
Journal:  Immunology       Date:  2019-11-12       Impact factor: 7.397

2.  Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8+ T cell responses in naïve and persistently infected mice and protects from challenge.

Authors:  Carolina Chiale; Safiehkhatoon Moshkani; John K Rose; Michael D Robek
Journal:  Antiviral Res       Date:  2019-05-30       Impact factor: 5.970

3.  New horizon for radical cure of chronic hepatitis B virus infection.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2016-07-28

4.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.

Authors:  Philipp Tropberger; Alexandre Mercier; Margaret Robinson; Weidong Zhong; Don E Ganem; Meghan Holdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

Review 5.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

6.  Combination Therapy Is the New Gene Therapy?

Authors:  Giuseppe Ronzitti; Federico Mingozzi
Journal:  Mol Ther       Date:  2017-12-20       Impact factor: 11.454

7.  Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.

Authors:  Meilan Cui; Ying Lv; Jianhua Lu; Wei Zhang; Yuanyuan Duan; Yan Huang; Lei Yang; Man Li; Wenxuan Liu; Dianwu Liu; Huimin Yan
Journal:  J Clin Lab Anal       Date:  2017-05-08       Impact factor: 2.352

8.  Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.

Authors:  Timothy M Block; Tianlun Zhou; Nikhil Anbarasan; Robert Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

9.  Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.

Authors:  Linmao Zhong; Wangqin Shu; Wangbin Dai; Bo Gao; Sidong Xiong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 10.  Eradication Strategies for Chronic Hepatitis B Infection.

Authors:  Eleanor M P Wilson; Lydia Tang; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.